VRCA - Balance Sheet - Verrica Pharmaceuticals Inc.

Current Liabilities	29 M
Accounts Payable	1.9 M
Short-Term Debt	13.6 M
Other Current Liabilities	13.5 M
Non-Current Liabilities	35 M
Long-Term Debt	32.3 M
Other Non-Current Liabilities	2.65 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	46.3	69.5	34.3	15.8	10.7	9.2	89.8	8.7	0.5
Short Term Investments	0	0	0	54.6	54.8	52.8	79.5	0	0
Receivables	77 K	4.4	0.5	0	0	0	0	0	0
Inventory	2.5	1.0	(0.5)	0	0	0	0	0	0
Other Current Assets	2.3	2.5	8.7	7.9	4.4	5.9	2.7	0.4	17 K
Total Current Assets	51.2	77.5	39.1	74.3	65.5	65.0	89.8	9.1	0.5
PP&E	2.6	3.6	5.6	5.8	4.9	2.2	0.3	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0.4	0	0	0
Other Long Term Assets	0.4	0.5	0	0	3.7	0.8	1.8	0	0
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	54.1	81.6	44.7	80.1	74.2	68.4	91.9	9.1	0.5
LIABILITIES
Accounts Payable	1.9	2.5	0.5	0.8	0.3	1.2	0.9	0.2	67 K
Short Term Debt	13.6	0.7	0.6	41.9	35.7	0.3	0	0	0
Other Current Liabilities	13.5	13.9	2.4	3.3	2.9	1.9	1.6	0.5	0.4
Total Current Liabilities	29.0	17.0	3.5	46.1	39.5	3.4	2.5	0.6	0.4
Long Term Debt	32.3	44.8	1.2	1.5	1.7	58 K	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	2.6	0	0	0	0	0	0	0	2.8
Total Liabilities	64.0	61.8	4.7	47.5	41.2	3.4	2.5	0.6	3.2
EQUITY
Common Stock	9 K	4 K	4 K	3 K	3 K	3 K	3 K	2 K	1 K
Retained Earnings	(307.0)	(230.4)	(163.5)	(139.0)	(103.9)	(61.2)	(33.1)	(12.4)	(2.7)
Other Accumulative Comprehensive Income/Loss	0	0	0	29 K	1 K	20 K	17 K	(15.5)	1 K
Total Equity	(9.9)	19.8	40.0	32.6	33.0	65.0	89.4	8.5	(2.7)
Total Liabilities and Equity	54.1	81.6	44.7	80.1	74.2	68.4	91.9	9.1	0.5
SHARES OUTSTANDING
Common Shares Outstanding	51.8	45.3	34.2	27.0	25.0	24.9	14.7	19.9	19.9

Free